David Flores, co-founder, President, and CEO of BioCentury, leads a vibrant discussion on the upcoming Grand Rounds conference in Nashville. They delve into the critical role of translating academic discoveries into marketable therapies and the unique challenges faced by the biotech industry. Special guests include experts from McKinsey and Candel Therapeutics, who provide insights into Nashville's emerging biotech ecosystem. The conversation also touches on the need for better collaboration between researchers and investors to elevate local innovations.
